Aripiprazole augmentation in treating comorbid bipolar disorder and obsessive-compulsive disorder: A systematic review.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of affective disorders"
DOI: 10.1016/j.jad.2019.02.024
Abstract: BACKGROUND Apparent comorbidity between bipolar disorder (BD) and obsessive-compulsive disorder (OCD) is a common condition in psychiatry, but treatment of BD-OCD remains a clinical challenge. Although serotonin reuptake inhibitors (SRIs) are the first line treatment… read more here.
Keywords: obsessive compulsive; disorder; disorder obsessive; bipolar disorder ... See more keywords
Real-world effectiveness and safety of aripiprazole augmentation therapy in patients with major depressive disorder
Sign Up to like & getrecommendations! Published in 2018 at "Current Medical Research and Opinion"
DOI: 10.1080/03007995.2018.1519317
Abstract: Abstract Aims: Augmentation therapy is an option for patients with major depressive disorder who do respond sufficiently to adequate dosages of selective serotonin reuptake inhibitors or serotonin–norepinephrine reuptake inhibitors, but little is known about application… read more here.
Keywords: safety; augmentation; patients major; therapy ... See more keywords
Aripiprazole augmentation in highly treatment-resistant obsessive–compulsive disorder – experience from a specialty clinic in India
Sign Up to like & getrecommendations! Published in 2017 at "International Journal of Psychiatry in Clinical Practice"
DOI: 10.1080/13651501.2016.1225098
Abstract: Abstract Objective: To study the effectiveness and tolerability of aripiprazole augmentation in patients with highly treatment-resistant obsessive–compulsive disorder (OCD) in a real-world scenario. Methods: We conducted a chart review of patients who were initiated on… read more here.
Keywords: highly treatment; treatment resistant; aripiprazole augmentation; obsessive compulsive ... See more keywords
Aripiprazole Augmentation to Mood Stabilizers for Obsessive-Compulsive Symptoms in Bipolar Disorder
Sign Up to like & getrecommendations! Published in 2020 at "Medicina"
DOI: 10.3390/medicina57010009
Abstract: Background and Objectives: Aripiprazole is a first-line agent in the treatment of bipolar disorder (BD) and available data demonstrates its efficacy on clinical symptoms in serotonin reuptake inhibitors-resistant obsessive-compulsive disorder (OCD) patients. Therefore, aripiprazole augmentation… read more here.
Keywords: obsessive compulsive; disorder; mood stabilizers; augmentation mood ... See more keywords